Finance

Lists
BLSM:NASDAQ
BlossomHill Therapeutics Inc
$26.25
+18.40%
(+4.08) 1D
$28.82
+9.79% (+2.57)
Pre-market
Closed: Sep 16, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLSM...
Open
$22.34
High
$27.11
Low
$22.01
Mkt. cap
804.40M
Avg. vol.
235.33K
Volume
339.00
52-wk high
$27.11
52-wk low
$15.25
EPS
-$2.32
No. of employees
63
Open
$22.34
High
$27.11
Low
$22.01
Mkt. cap
804.40M
Avg. vol.
235.33K
Volume
339.00
52-wk high
$27.11
52-wk low
$15.25
EPS
-$2.32
No. of employees
63
News stories
From web sources and news partners
About BlossomHill Therapeutics Inc
CEO-
Employees63
Founded2020
Headquarters-
SectorPharmaceutical industry
Websitebhtherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to BLSM in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BLSM in the last 3 months.
Highest
Current $26.25
$35.00 (+33.33%)
Average
$31.25 (+19.05%)
Lowest
$28.00 (+6.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Charles Zhu
LifeSci Capital
Buy
Maintained
$32.00
+21.9%
09/15/2026
Michael Schmidt
Guggenheim
Buy
Initiated
$30.00
+14.3%
09/01/2026
Robert Burns
H.C. Wainwright
Buy
Initiated
$35.00
+33.3%
09/01/2026
Brian Cheng
J.P. Morgan
Buy
Initiated
$28.00
+6.7%
09/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
9.57M
19.90M
Total research and development expenses
-
-
Selling, general, and admin expenses
1.88M
2.21M
Operating expense
11.45M
22.11M
Total operating expenses
11.45M
22.11M
Operating income
-11.45M
-22.11M
Other non operating income
-
-
EBT including unusual items
-10.48M
-21.01M
EBT excluding unusual items
-10.48M
-21.01M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-10.48M
-21.01M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
976.00K
1.10M
Interest expense
-
-
Net interest expenses
976.00K
1.10M
Depreciation and amortization charges
-
-
EBITDA
-11.37M
-21.98M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps